Showing results (21-30 of 93) with videos related to
Sort By:
Pageof 10
Bioconjugate Chemistry|February 4, 2016
New Chelators for Low Temperature Al(18)F-Labeling of BiomoleculesFrederik Cleeren, Joan Lecina, Emilie M F Billaud, et al.Journal of Neurochemistry|September 25, 2016
[18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMPMaarten Ooms, Bala Attili, Sofie Celen, et al.Nuclear Medicine and Biology|September 23, 2003
Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human useKristin Verbeke, Davy Kieffer, Jean-Luc Vanderheyden, et al.Molecular Imaging and Biology|March 20, 2013
Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjectsRawaha Ahmad, Michel Koole, Nele Evens, et al.Drug Delivery|January 15, 2014
Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarctionMarlein Miranda Cona, Yuanbo Feng, Jian Zhang, et al.International Journal of Oncology|December 25, 2013
Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeuticMarlein Miranda Cona, Michel Koole, Yuanbo Feng, et al.Frontiers in Neuroscience|October 8, 2016
Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [11C]MA2 and [18F]MA3Muneer Ahamed, Daisy van Veghel, Christoph Ullmer, et al.European Radiology|January 24, 2006
Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis-avid contrast agentYicheng Ni, Feng Chen, Stefaan Mulier, et al.Targeted Oncology|February 22, 2012
A review on various targeted anticancer therapiesJunjie Li, Feng Chen, Marlein Miranda Cona, et al.Contrast Media & Molecular Imaging|June 5, 2007
Evaluation of tumor affinity of mono-[(123)I]iodohypericin and mono-[(123)I]iodoprotohypericin in a mouse model with a RIF-1 tumorHumphrey Fonge, Marie Van de Putte, Dieter Huyghe, et al.Pageof 10